ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,460 | -17.7% | 5,986 | -6.7% | 0.04% | -39.7% |
| Q2 2023 | $197,289 | -5.3% | 6,418 | +11.0% | 0.06% | -13.4% |
| Q1 2023 | $208,325 | +131.5% | 5,782 | +157.8% | 0.07% | +52.3% |
| Q3 2022 | $90,000 | -6.2% | 2,243 | -1.3% | 0.04% | -25.4% |
| Q2 2022 | $96,000 | +7.9% | 2,273 | +1.3% | 0.06% | +43.9% |
| Q4 2021 | $89,000 | +41.3% | 2,243 | +29.6% | 0.04% | +2.5% |
| Q3 2021 | $63,000 | – | 1,731 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |